Uncovering the material basis and mechanism of Jianwei Xiaoshi tablet against functional dyspepsia using ultra‐high‐performance liquid chromatography‐mass spectrometry and network pharmacology
Biomedical Chromatography · 2024
DOI: 10.1002/bmc.5990 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2024. Verfasst von Xiaoxu Cheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development Department, Jiangzhong Pharmaceutical Co., Ltd., Nanchang, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Dyspepsia, Mass Spectrometry, Tablets. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Major New Drug Development, Project of Major Science and Technology.
Abstract (Originalsprache)
Functional dyspepsia (FD) is a common digestive disease. Jianwei Xiaoshi (JWXS) tablet is composed of Radix Pseudostellariae (TZS), Pericarpium Citri Reticulatae (CP), Rhizoma Dioscoreae (SY), fired Hordei Fructus Germinatus (CMY) and Crataegi Fructus (SZ). It is a commonly used drug in the treatment of FD in China and has good therapeutic effects. However, there is very little research about the substance basis and action mechanism of JWXS tablet. In this research, ultra‐high‐performance liquid chromatography‐mass spectrometry (UPLC‐MS) and network pharmacology were used to explore the substance basis and action mechanism of the JWXS tablet. Finally, 19, 79, 22, 22 and 39 constituents were identified in the extracts of TZS, CP, SY, CMY and SZ, respectively. Based on these findings, a total of 104 ingredients were identified in JWXS tablet and 29 potentially absorbed ingredients were detected in rat plasma. The results of network pharmacology indicated that the inhibition of gastric acid secretion, the regulation of gastrointestinal motility, inflammation and immune response were the key approaches for treating FD with JWXS tablet. The material basis and potential action mechanism of JWXS tablet in treating FD were comprehensively clarified for the first time. This study will improve our understanding of JWXS tablet.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research and Development Department, Jiangzhong Pharmaceutical Co., Ltd., Nanchang, China.
- National Key Laboratory for the Modernization of Classical and Famous Prescriptions of Chinese Medicine, Nanchang, China.
ORCID-Profile: Wenjun Liu
Förderung
- Major New Drug Development, Project of Major Science and Technology
Zitieren
APA
Cheng, X., Zhang, W., Huang, C., Hu, P., Li, H., Li, Y., Xiong, Y., & Liu, W. (2024). Uncovering the material basis and mechanism of Jianwei Xiaoshi tablet against functional dyspepsia using ultra‐high‐performance liquid chromatography‐mass spectrometry and network pharmacology. Biomedical Chromatography. https://doi.org/10.1002/bmc.5990
Vancouver
Cheng X, Zhang W, Huang C, Hu P, Li H, Li Y, et al. Uncovering the material basis and mechanism of Jianwei Xiaoshi tablet against functional dyspepsia using ultra‐high‐performance liquid chromatography‐mass spectrometry and network pharmacology. Biomedical Chromatography. 2024. doi:10.1002/bmc.5990
BibTeX
@article{Cheng2024,
author = {Cheng, Xiaoxu and Zhang, Wanqiao and Huang, Chaodong and Hu, Pei and Li, Hongchang and Li, Yiguang and Xiong, Yanxia and Liu, Wenjun},
title = {Uncovering the material basis and mechanism of Jianwei Xiaoshi tablet against functional dyspepsia using ultra‐high‐performance liquid chromatography‐mass spectrometry and network pharmacology},
journal = {Biomedical Chromatography},
year = {2024},
doi = {10.1002/bmc.5990}
}
EUVIMED